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Abstract: Background: Syncope is a transient loss of consciousness due to transient decrease in cerebral perfusion. 
Syncope accounts for a 3-6% of all emergency department visits. Etiology of syncope can be neural, cardiogenic, or 
vascular. Previous studies have evaluated the types and management of syncope. Echocardiography is a commonly 
used test in the evaluation of causes of syncope. Whether the benefit compared to financial burden of this diag-
nostic study is in all subsets of syncope cases remains unclear. Aim: To evaluate the impact of echocardiography in 
the diagnostic evaluation of syncope and to evaluate the subset of patients that would benefit more from this diag-
nostic imaging. Methods: We performed a retrospective chart review of patients > 18 years of age with a primary 
diagnosis of syncope in a period of January 1st 2015-January 31st 2017. Our inclusion criteria included patients > 
18 years of age who were admitted to the observation floor with the primary complaint as syncope, had a normal 
or abnormal physical examination for syncope, had a normal or abnormal electrocardiogram during admission, had 
an echocardiography performed at admission. Our exclusion criteria included patients with seizures, hypoglycemia, 
myocardial infarction, patients who didn’t get echocardiography, and patients who had a positive marker of cardiac 
injury. Results: A total of 369 patients were initially identified with a primary diagnosis of syncope, however only 
120 of these patients fulfilled our inclusion and exclusion criteria. A total of n=25 of included patients had either 
an abnormal physical exam or abnormal echocardiography. Among this “high risk” group, 24% (n=6) of the patients 
had an abnormal finding on their transthoracic echocardiography. On the other hand, in the “low risk” group with 
a normal physical examination and electrocardiogram (EKG), 14 had a trans-thoracic echocardiography (TTE) posi-
tive for cause of syncope, that led to a change in medication, workup, or intervention in 6.7% (n=8) of the patients. 
Conclusion: The analysis of our study suggested that the diagnostic yield of transthoracic echocardiography in syn-
cope is very limited in the absence of an abnormal physical exam or electrocardiogram, and it increase the health 
care cost burden with no additional benefits. 
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Introduction
Syncope is a form of temporary loss of con-
sciousness with no focal neurologic deficits. It 
is usually secondary to a transient decrease 
in the blood supply of the brain resulting in loss 
of the ability to maintain posture. Syncope is 
oftentimes self-resolving and doesn’t require 
any intervention [1]. Syncope accounts for up to 
3-6% of ED visits. Out of all syncope presenta-
tions to the emergency department, 40% of 
these patients get admitted. In admitted pati- 
ents, a detailed workup is usually a practice of 
most of hospitals [2-4]. Furthermore, the recur-
rence rate of syncope admission cases acco- 
unts for up to 35% [4]. In addition, the lifetime 
probability of getting syncope is 42% in a lifes-
pan of 70 years that results in an annual inci-
dence rate of 6% [5]. The incidence of syncope 
increases exponentially with an increase in age. 
Syncope was reported to occur in 15% of the 
patients < 18 years of age, and around 23% in 
age > 18 years [6, 7]. A reported incidence of 
syncope in patients age > 60-69 is 5.7 epi-
sodes/1000 people per year and for patients > 
70 years is 11.1/10000 people per year [7-9]. 
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In patients > 80 years of age, the annual inci-
dence of syncope reaches up-to 19.5 epi-
sodes/1000 people [9].
Syncope is broadly divided into neurogenic, 
vascular, and cardiogenic. A combination of a 
physical examination, orthostatic vitals, and an 
electrocardiogram play a key role in diagnosis 
of syncope and its subtypes. A complete histo-
ry/physical examination holds a great signifi-
cance in categorizing the type of syncope, and 
should include the presence of precipitating 
factors, presence of prodrome, association 
with a change in posture, trauma, associated 
symptoms including palpitation, dyspnea, chest 
pain, cyanosis, nausea, and vomiting [4]. Physi- 
cal examinations should include orthostatic 
vitals over the 3-5 minute gap between sitting 
and standing, along with a cardiovascular and 
detailed neurological examination [4]. Physical 
examinations should also be focused to rule 
out secondary causes of loss of consciousness 
including seizures, metabolic abnormalities, st- 
roke, and trauma. The electrocardiogram holds 
a great significance in ruling out cardiovascular 
causes of syncope [3, 4]. The role of echocar-
diography in diagnostic evaluation of all cases 
of syncope remains unclear, specifically in rou-
tine evaluation. Only studies justified its routine 
evaluation in cases of syncope by history, phys-
ical examination, and electrocardiogram. 
Our analysis is focused to see the results of 
echocardiography in all cases of syncope, and 
correlate whether all cases should get a base-
line echocardiography on admission. Our study 
also evaluated the frequency of ordering echo-
cardiography in patients with syncope and nor-
mal physical exams and electrocardiograms in 
the observation unit. 
Materials and methods
Ethical considerations 
This study was designed with the combined 
knowledge and expertise of faculty of Abington-
Jefferson Health. This study strictly follows the 
Helsinki Ethical guidelines for animals and hu- 
mans. It also maintains the confidentiality of 
the participants. 
Patient populations and definitions
We performed a retrospective observational 
cohort study to determine the frequency of 
ordering echocardiography in patients with syn-
cope on the observation floor and who have a 
normal physical exam and electrocardiogram, 
and the frequency of positive findings in this 
population group. We included all the patients 
who were over 18 years of age that were admit-
ted to our observation floor with the primary 
diagnosis of syncope from January 1st, 2015 to 
January 31st, 2017. Inclusion criteria also con-
stitutes of patients who got electrocardiogram 
and echocardiography. Abnormal EKG findings 
include arrhythmia, Q waves, ischemic chang-
es, 2nd/3rd degree AV block, paced rhythm, QTc 
> 500 ms, left bundle branch block, bi-fascicu-
lar block, Abnormal Axis, and Brugada pattern. 
Abnormal echocardiography includes right/left 
ventricular hypertrophy, right/left ventricular 
dysplasia, valvular dysfunction including steno-
sis or regurgitation, and low left/right ventricu-
lar ejection fraction. Included patients also con-
stitutes of normal or abnormal physical exam. A 
physical exam that constitutes abnormal crite-
ria includes jugular venous distention, systolic/
diastolic murmurs, S3, S4, and loud S1. Ex- 
clusion criteria included patients whose symp-
toms could be explained by other medical con-
ditions like seizures, hypoglycemia, and MI, 
patient who were transferred to acute care, 
patients who left against medical advice, 
patients who did not get an echocardiogram, 
and patients who had positive cardiac biomark-
ers. Our study population after applying the 
inclusion and exclusion criteria was 120 
patients. The demographic and clinical charac-
teristics of these patients were taken into 
account. 
Study population
Among the patient population in hospital loca-
tion, age, and gender variables were studied. 
Among this population, the following comorbidi-
ties were studied: hypertension, diabetes mel-
litus, prior myocardial infarction, prior percuta-
neous intervention, chronic kidney disease, 
prior cardiovascular accident, peripheral vascu-
lar disease, anemia, and prior syncope.
Statistical analyses 
Descriptive analysis was utilized to describe 
the population with syncope and echocardiog-
raphy. A mean + SD was reported for continu-
ous variables. A percentage and absolute num-
bers were used for categorical variables. In 
order to test for difference in the proportion of 
the variables, Fischers exact test was used. 
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Results
The analysis of our study involved patient popu-
lation with an age greater or less than 65 years, 
and admitted to the observation unit for syn-
tients with abnormal physical exam, and abnor-
mal orthostatic vitals. Our sample mostly had a 
normal physical exam in 84.2% of the patients 
and only 15.8% of patients had an abnormal 
exam including heart murmurs, with no carotid 
bruit. Further review, also showed that 98.3% 
of patients had normal orthostatic vitals. Only 2 
patients in our sample had abnormal orthostat-
ic vitals. The analysis of physical exam, and 
orthostatic vitals are shown in Table 3.
Analysis of electrocardiogram review in out 
patient population showed that 82.5% (n=99) 
of the patients had a normal baseline sinus 
rhythm with no arrythmias. Arrythmias preva-
lence review in our sample includes atrial fibril-
lation (6.7%, n=8), left bundle branch block 
(1.7%, n=2), with no right bundle branch block, 
or any other arrythmias. An analysis of EKG 
findings is shown in Table 4. 
Analysis of echocardiographic review of our 
patient sample showed aortic stenosis as a 
most common echocardiographic finding in 
our sample with a prevalence of 18.3%, n=22. 
Other percentage of echocardiographic find-
ings include mitral regurgitation (5.8%, n=7), 
left ventricular systolic dysfunction (5%, n=6), 
Table 1. This table depicts the demographic variables 
of a study sample
Patient demographics Percentage (%)
Total patient population 120 (100%)
Age > 65 years 54.2%
Age < 65 years 45.8%
Males 45.8%
Females 54.2%
Table 2. This table depicts the associated comorbidi-






of the  
population
Hypertension 61 50.8%
Diabetes Mellitus 39 32.5%
Chronic Kidney Disease 23 19.2%
Prior Myocardial infarction 22 18.3%
Prior syncope 20 16.7%
Prior percutaneous intervention 20 16.7%
Prior cerebrovascular accident 4 3.3%
Peripheral vascular disease 0 0%
Anemia 0 0%
cope evaluation. A total of 120 patients 
meet our inclusion criteria for syncope 
evaluation on observation floor. Among 
the sample of 120 patients, 54.2% were 
above 65 years of age, 45.8% were under 
65 years of age. The gender difference of 
included sample showed that 45.8% were 
males, and 54.2% were females. A demo-
graphic variable of patient population is 
shown in Table 1.
The included study population also had 
secondary comorbid. A subgroup analysis 
of co-morbidities showed hypertension as 
a most prevalent among study sample with 
up-to 50.8% prevalence. The prevalence 
of other comorbidities includes diabetes 
(32.5%), chronic kidney disease (19.2%), 
prior myocardial infarction (18.3%), prior 
percutaneous intervention (16.7%), prior 
syncope (16.7%), prior cerebrovascular 
event (3.3%). Furthermore, our study sam-
ple didn’t have any patients with anemia, 
or peripheral vascular disease. A co-mor-
bidities analysis is shown in Table 2. 
To subcategories the patients that need 
further testing, we subcategories the pa- 
Table 3. This table depicts the physical exam 
findings and abnormal vitals in our patient 
population
Parameters
Percentage of the population 
(total n=120)
Normal Abnormal
Physical Exam 84.2% (n=101) 15.8% (n=19)
Orthostatic vitals 98.3% (n=118) 1.7% (n=2)
Table 4. This table depicts the rhythm abnor-






of the  
population
Normal Sinus Rhythm 99 82.5%
Atrial fibrillation 8 6.7%
Atrial flutter 0 0%
LBBB 2 1.7%
RBBB 0 0%
Echocardiography on observational unit
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aortic regurgitation (0.8%, n=1), and no mitral 
stenosis, or other valvular or cardiac patholo-
gies. The echocardiographic findings analysis is 
shown in Table 5. 
For management of our patient sample, 2 
patients (1.6%) with new LBBB got cardiac 
catheterization performed for evaluation of 
ischemia. Other patients of syncope on obser-
vation floor were managed symptomatically by 
medication review, controlling inciting agent, or 
further workup in only 6.66% (n=8). The patient 
outcome of management/workup of positive 
echocardiographic and EKG findings are shown 
in Table 6. 
In our study sample, head to head review of 
electrocardiogram and echocardiographic find-
ings of a study sample depicted 15% (n=3) of 
the patients had a positive EKG and echocar-
diographic findings for syncope cause with a 
ple. The patients with a positive TTE findings 
with a murmur vs no murmur (P=0.01), abnor-
mal EKG vs normal EKG (P=0.046), and prior 
PCI vs no PCI (P=0.05). The results of positive 
TTE findings, and subgroup of orthostatic vitals 
abnormal vs normal orthostatic vitals were not 
statistically significant (P=1.00) likely 2/2 to 
low population sample. The analysis of sub-
group difference of findings is shown in Table 8. 
Discussions
Syncope is a condition where the blood supply 
to the brain is reduced for various reasons, and 
results in an inability to maintain postural tone 
for a while. It has many causes, though they 
can be broadly classified into 4 main catego-
ries. These are reflex syncope or neural synco-
pe, orthostatic syncope, cardiac arrhythmia, 
and cardiopulmonary disease leading to synco-
pe. Some other conditions that can present 
Table 5. This table depicts the echo findings in our patient population
Echocardiographic findings Number of patients  
(total n=120)
Percentage of  
the population
Aortic Stenosis 22 18.3%
Mitral Regurgitation 7 5.8%
Left ventricular systolic dysfunction (LVEF < 50%) 6 5%
Aortic Regurgitation 1 0.8%
Mitral Stenosis 0 0%
Table 6. Patient outcomes with a positive echocardiographic finding
Treatment/Procedure performed Frequency Out of total sample
Cath performed 98.4% 1.6%
Medication review, management workup, or further workup 93.44% 6.66%
Table 7. This table depicts the prevalence of positive TTE findings in both the normal and abnormal 
physical exam findings groups
Physical exam normal/abnormal echocardiography  positive
echocardiography  
negative
Total patients  
n=120
Normal 7/99 (7%) 93/99 (93%) n=99 (84.2%)
Abnormal 3/21 (15%) 17/21 (85%) n=21 (15.8%)
Table 8. This table depicts the subgroup analysis comparison in 
patients with a positive TTE
Difference between positive TTE findings in various groups Significance level
Murmur Positive vs no Murmur (Physical exam findings??) P=0.01
Abnormal EKG vs Normal EKG P=0.046
Orthostatic Vitals vs no Orthostatic vitals P=1.000
Prior PCI vs no Prior PCI P=0.059
statistically significant results 
(P=0.001). Furthermore, 7% 
(n=7) of patients had an abnor-
mal echocardiographic finding 
with a normal EKG. Analysis of 
echocardiographic and physi- 
cal examination is shown in 
Table 7. 
A subgroup difference was also 
evaluated in positive TTE sam-
Echocardiography on observational unit
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similarly but need to be differentiated from syn-
cope include seizure disorders, accidental falls, 
sleep disturbances, and conversion disorder. 
Most of the causes of syncope are relatively 
benign, besides the risks inherent to falls. 
Cardiac syncope which includes syncope from 
vascular disease, cardiomyopathy, arrhyth-
mias, and valvular dysfunction, may be associ-
ated with increased mortality and need more 
attention. The other causes of syncope do not 
increase mortality on their own, but can result 
in significant morbidity and disability due to 
accidents and falls that may occur as a result 
[10]. Besides this, there is also the social 
impact including the worsening of the quality of 
life, and the economic impact due to hospital-
izations. It is estimated that this cost may be up 
to 2.4 billion dollars annually [11]. 
All cases of syncope need to be further evalu-
ated, to rule out any underlying sinister pathol-
ogy and to help prevent recurrence. This evalu-
ation usually starts with a detailed history fo- 
cused but not limited to asking about the symp-
toms onset, any inciting factor(s), any symp-
toms just prior to the episodes, and also the 
past medical history. This is usually followed by 
checking orthostatic vitals and a detailed phys-
ical exam also focused on the cardiovascular 
and neurologic systems, and to identify any hid-
den trauma. Many of the cases of syncope like 
vasovagal and orthostatic hypotension can 
easily be identified based on history and a 
physical exam. Many other cases however re- 
quire further evaluation and workup. This usu-
ally entails some form of cardiac workup, and 
usually starts with an electrocardiogram. Some 
of the arrhythmias can be detected by this, 
however, paroxysmal arrhythmias may not be 
picked up by a 12-lead EKG. Such patient may 
require further evaluation with a holter monitor 
or a loop recorder if the index of suspicion is 
high. An electrocardiogram on the other hand 
will not help much with the diagnosis of synco-
pe secondary to structural heart disease or car-
diopulmonary disease. These patients would 
need to undergo an evaluation by a transtho-
racic echocardiography (TTE).
Syncope patients who are suspected to have a 
cardiac origin of their syncope usually also 
undergo transthoracic echocardiography [12]. 
It can be helpful in both finding the underlying 
cause and also stratifying the severity of any 
underlying cardiac lesion, like hypertrophic car-
diomyopathy, aortic stenosis, and left ventricu-
lar dysfunction [13-15]. It is one of the most 
useful imaging modalities for evaluating the 
severity of an underlying cardiac disease, and 
also the risk stratification of patients who have 
unexplained syncope. It is especially useful in 
patients who have an abnormal electrocardio-
gram or patients with a known positive cardiac 
history [16]. The exact role of echocardiography 
in the workup of syncope is still not clear, espe-
cially in syncope patients who do not have any 
known history of cardiac conditions and no indi-
cation of cardiac pathology in their history, 
physical examination, and initial workup of syn-
cope [17, 18]. On the other hand, in patients 
with an abnormal electrocardiogram or cardiac 
history, a transthoracic echo is usually recom-
mended as part of the evaluation of syncope 
[19, 20]. Due to the significant use of financial 
and manpower resources associated with ec- 
hocardiography, studies have been previously 
conducted to elucidate the role of echocardi- 
ography in syncope patients. There have been 
attempts to better streamline the approach of 
doing echocardiography in patients presenting 
with syncope [21, 22].
Transthoracic echocardiography is used widely 
in clinical practice as a screening tool to rule 
out valvular or structural heart disease in 
patients who present with syncope. It is espe-
cially significant in patients who have underly-
ing cardiomyopathy and present with unex-
plained syncope and also have abnormal find-
ings on their physical exam or an abnormal 
electrocardiogram. Transthoracic echocardiog-
raphy on the other hand in patients with a nor-
mal physical exam and normal electrocardio-
gram is not a very high yield, and it adds to the 
additional cost to the patient. Transthoracic 
echocardiography costs around 1000 dollars 
on average in the US. Inappropriately perfor- 
med transthoracic echocardiogram may in- 
crease the cost of healthcare.
Though the role of transthoracic echo is well 
established in patients who have some under-
lying cardiac disease, however there have been 
questions regarding the utility of echocardiog-
raphy in other patient groups. Current ACC/AHA 
guidelines recommend that all the patients who 
have a positive cardiac history, or have findings 
in the patient’s history and physical, are recom-
mended to undergo a transthoracic echocar-
diography [23, 24]. 
Echocardiography on observational unit
132 Am J Cardiovasc Dis 2019;9(6):127-133
There have been studies done previously to 
better elucidate the role of transthoracic echo-
cardiography in syncope. Recchia et al descri- 
bed a retrospective review in which they found 
that 48% of the patients who had a suspected 
cardiac origin of the syncope based on history, 
physical exam, or electrocardiogram had an 
abnormal transthoracic echo [21]. The abnor-
mal echo was not necessarily the underlying 
reason for the syncope.
Sarasin et al in another prospective study of 
650 patients, found that 24 out of 88 patients 
found to have an abnormal electrocardiogram 
were also found to have left ventricular systolic 
dysfunction on echocardiography. A clinically 
significant arrhythmia was also present in 
around half of the patients [12]. Our study also 
indicates that echocardiography is more useful 
and has a higher yield in high risk patients. As 
such, our study is consistent with previous 
studies described above.
Limitations
Our retrospective study is small and is not as 
significant as a large prospective study would 
be. Secondly, the physical exam findings and 
echocardiogram reads can be variables betwe- 
en different examiners. Also, the diagnosis of 
syncope can be subjective and was based on 
patient reported symptoms in our study. One 
other limitation was that we did not have any 
follow up with our patients after discharge. 
Conclusion
In conclusion, TTE has a low diagnostic yield in 
patients with normal physical exams/electro-
cardiograms and a high diagnostic yield in 
patients with abnormal physical examinations/
electrocardiograms respectively. 
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